Next Article in Journal
The Influence of External Breast Prostheses on the Body Postures of Women Who Have Undergone Mastectomies
Next Article in Special Issue
The Association between Autoimmune Thyroid Disease and Ocular Surface Damage: A Retrospective Population-Based Cohort Study
Previous Article in Journal
Low-Dose Propofol with Peribulbar Anaesthesia for Cataract Surgery
Previous Article in Special Issue
Adherence to Annual Fundus Exams among Chinese Population with Diagnosed Diabetes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Impact of Color Vision Deficiency on the Capability of Ophthalmologists to Diagnose Benign and Malignant Choroidal Tumors

1
Division of Ophthalmology, Department of Special Surgery, School of Medicine, The University of Jordan, Amman 11942, Jordan
2
Department of Surgery (Ophthalmology), King Hussein Cancer Center, Amman 11941, Jordan
3
Ophthalmology Department, Faculty of Medicine, Mutah University, Mutah 61710, Jordan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(7), 2744; https://doi.org/10.3390/jcm12072744
Submission received: 17 January 2023 / Revised: 14 February 2023 / Accepted: 24 February 2023 / Published: 6 April 2023
(This article belongs to the Special Issue Advances in Vision Disorders: Causes and Epidemiology)

Abstract

:
Background: Color vision deficiency (CVD) is an under-reported problem among medical personnel, and its impact is still not well characterized. We aim to assess the impact of CVD among ophthalmologists on the accuracy of diagnosing different benign and malignant choroidal lesions. Methods: This is a cross-sectional study conducted on ophthalmologists. We used a web-based survey to collect responses through professional ophthalmology society social media. The survey included a set of five images for normal fundus, choroidal nevus, circumscribed choroidal hemangioma, choroidal metastasis, and choroidal melanoma, wherein each image simulated the three main types of CVD: protanopia, deuteranopia, and tritanopia, in addition to a non-simulated image. Results: Forty-one participants were included, with a mean age of 40 (±9.2) years. They were 28 (68%) men and 13 (32%) women. Participants showed significantly low accuracy for definite diagnosis for circumscribed choroidal hemangioma, nevus, melanoma, and metastasis when the images simulated protanopia and deuteranopia, but not tritanopia. Nevertheless, participants maintained the capability to recognize the nature of the lesions for both simulated and non-simulated images if they were benign or malignant, thereby ensuring immediate referral for specialized care. The exception was with simulated choroidal nevi images, wherein participants incorrectly assigned simulated protanopia and deuteranopia nevi images to malignant lesions. Conclusion: Protanopia and deuteranopia affected the accuracy of diagnosing several choroidal lesions; however, ophthalmologists with those two simulated CVDs were still able to discriminate between benign and malignant tumors.

1. Introduction

Color vision deficiency (CVD) refers to the inability to distinguish certain shades of color. The estimated prevalence of this problem in the general population has been reported to be up to 8% among males (0.4% among females), with similar figures estimated for medical personnel [1,2].
There are several types of CVD that can be either acquired or congenital. Anomalous trichromacy refers to an abnormality in the alignment of one of the three cones that result in reduced sensitivity to a particular color. If the sensitivity to red is reduced, it is termed protanomaly; if the sensitivity to green is reduced, deuteranomaly; and if the sensitivity to blue is reduced, tritanomaly. Dichromacy occurs when there are only two functioning retinal cones that perceive color with the absence of one cone type. The three types of dichromacy are protanopia, deuteranopia, and tritanopia. Finally, monochromacy refers to having no cones or only one type of cone, which results in no color perception [3]. Despite its relatively high prevalence, many people may be living with the condition while being completely unaware of it.
In ophthalmic practice, the diagnosis of choroidal tumors is primarily clinical without the need for pathologic confirmation. The ocular oncologist relies mainly on clinical features including the color of the lesion to diagnose these lesions. Melanoma is generally a thick melanotic choroidal lesion, while circumscribed hemangioma is orange in color, and metastasis appears creamy yellow. Posterior uveal melanomas are often seen as a raised, dome-shaped lesion with a gray-brown color and uneven margins. Occasionally, a melanoma may lack pigmentation. Other possible causes of choroidal lesions include a benign or suspicious nevus, hemorrhagic macular degeneration, metastasis, hemangioma, hamartoma of the retina or retinal pigment epithelium, diffuse melanocytic proliferation, or detachment of the pigment epithelium, retina, or choroid. Ciliary body tumors that can resemble a melanoma include iridociliary epithelial cysts, intraocular foreign body granulomas, melanocytic nevi, melanocytomas, leiomyomas, Fuchs adenomas, sarcoid nodules, and metastatic tumors. During the evaluation of a suspicious choroidal lesion, various clinical characteristics such as color, thickness, subretinal fluid, orange pigments, drusen, halos, and others should be examined. Color is an important diagnostic characteristic of choroidal tumors, with melanomas usually exhibiting shades of brown, gray, black, or white, and haemangiomas often appearing orange-red. Most metastases appear white, except for renal and carcinoid secondaries, which may appear orange [4,5,6,7,8,9,10,11,12,13,14,15].
Therefore, we theorize that ophthalmologists who have problems defining colors correctly may fail to diagnose these conditions correctly, and this may cause delayed referral and treatment, and consequently serious morbidity and mortality for patients. The effect of having CVD on the accuracy of differentiating and diagnosing benign and malignant fundus lesions among ophthalmologists has never been studied before; therefore, the aim of this study is to assess the impact of simulated CVD on the accuracy of diagnosing different benign and malignant choroidal lesions among ophthalmologists.

2. Methods

2.1. Study Design and Participants

This is a cross-sectional study conducted on ophthalmologists from Jordan. We obtained institutional review board approval from the King Hussein Cancer Center (22 KHCC 008), and participants gave consent regarding their participation. We conducted this research in concordance with the latest Helsinki declaration. We used a web-based survey to collect responses. We distributed the survey through professional ophthalmology society social media, wherein we targeted Jordanian general ophthalmologists, retinal specialists, and ocular oncologists.

2.2. CVD Simulation and Assessment

Using an online form, the nature of the project was described, and participants signed up to partake in the study. The rater was first asked to take an online color vision deficiency test to confirm the absence of preexisting CVD. The questionnaire then asked about their demographic variables (i.e., age, gender, and occupation), in addition to specialty and years of practice. This was followed by a brief overview of the characteristics of choroidal nevus, circumscribed hemangioma, metastasis, and melanoma. After that, a set of five images for normal fundus, choroidal nevus, circumscribed choroidal hemangioma, choroidal metastasis, and choroidal melanoma were presented. Images were extracted from the database of the King Hussein Cancer Center. Each image was then altered to simulate the three main types of color vision deficiency, namely protanopia, deuteranopia, and tritanopia, and were stored in addition to a non-simulated image. Figure 1, Figure 2, Figure 3, Figure 4 and Figure 5 show fundus images for normal fundus, circumscribed hemangioma, metastasis, malignant melanoma, and nevus along with their simulated protanopia, deuteranopia, and tritanopia variants.
Twenty fundus images with these different benign and malignant lesions were randomly distributed representing four sets of five: simulated protanopia images, simulated deuteranopia images, simulated tritanopia images, and non-simulated images. Participants were requested to answer two main multiple-choice questions for each image (a total of 20 images for each participant); one asked about the definite diagnosis of the disease and the other asked if the lesion was benign (and does not need an immediate referral to an ocular oncologist) or malignant (and needs immediate referral). Benign images included a normal fundus image, choroidal nevus, and circumscribed choroidal hemangioma. Malignant images included choroidal melanoma and choroidal metastasis. Thereafter, participants were considered to have a passing score in a set if they correctly answered the questions for at least three out of the five images in that set. All participants who failed to correctly diagnose the normal fundus photo in a non-simulated image were excluded from this study.
To transform fundus images into what a protanope, deuteranope, and tritanope ophthalmologist can see, we used the Vischeck color blindness simulator in Fiji software [16], which has been proved to be highly accurate in simulating colorblind images [17].

2.3. Statistical Analysis

We used SPSS version 26.0 (Chicago, IL, USA) in our analysis. We used mean (±standard deviation) to describe continuous variables. We used count (frequency) to describe other nominal variables. We used Fischer exact tests to analyze the difference between the number of correctly diagnosed images between specialties. All underlying assumptions were met. We adopted a p-value of 0.05 as a significant threshold.

3. Results

A total of 41 participants were included in this study, with a mean age of 40 (±9.2) years. They were 28 (68%) men and 13 (32%) women. Two-thirds were general ophthalmologists 28 (68%), while 13 (32%) were retinal specialists or ocular oncologists. The average number of years in practice for included participants was 11.2 (±7.6) years, ranging from one year to 35 years.
All participants correctly diagnosed normal images when non-simulated. However, participants had significantly low accuracy for definite diagnosis for normal fundus images as well as for circumscribed hemangioma, nevus, melanoma, and metastasis when the images simulated protanopia and deuteranopia, which was not the case for tritanopia (Table 1). On the other hand, participants could correctly decide if the lesions for both simulated and non-simulated images were benign or malignant, thus mandating referral for specialized care. The exception was in the nevi simulated images, where participants incorrectly assigned simulated protanopia and deuteranopia images for nevi as “needs referral”, with p values of 0.007 for simulated protanopia and 0.003 for simulated deuteranopia images (Table 1).
When we evaluated the overall score for the questionnaire for each set of images (considering correct answers for at least 3 out of the 5 questions as a passing score) for diagnosis of intraocular tumors, we found that participants with simulated protanopia and deuteranopia images had a significantly higher score deciding whether the lesion was benign or malignant compared to giving a correct definite diagnosis. This indicates good ability to realize the nature of the lesion (benign vs. malignant) but limited capability to recognize the exact pathology behind each image in this group with CVD (Table 2). There was no significant difference between general ophthalmologists versus ocular oncologists and retina specialists regarding definite diagnosis or discriminating capability between benign and malignant lesions (Table 2), even though ocular oncologists and retinal specialists showed relatively better scores for definite diagnosis with simulated protanopia and deuteranopia images when compared to general ophthalmologists.

4. Discussion

Many aspects of modern-day life necessitate accurate color vision, and these can range from simple everyday tasks to more complex color-dependent functions. This study aims to assess the impact of CVD on the accuracy of diagnosing different choroidal lesions, using a high-quality simulation on a diverse group of ophthalmologists. We found that ophthalmologists with simulated protanopia and deuteranopia are not able to correctly diagnose the exact pathology in patients with benign and malignant choroidal tumors, even though they still have the capability to recognize whether the choroidal lesion was a benign lesion that needs observation or a malignant lesion that mandates referral to an ocular oncologist for immediate treatment. Color blindness did not affect the capability of experts in eye tumors (ocular oncologists and retinal specialists) to correctly diagnose the exact pathology in the choroid; however, general ophthalmologists had a more dramatic decrease in their capability of diagnosing the pathology of different choroidal tumors correctly.
The results of our current study go hand-in-hand with a recently published study that assessed the impact of CVD on diabetic retinopathy staging, wherein graders with color vision deficiency had lower staging accuracy, a difference that was more pronounced among protanopic graders [18].
The increasing evidence in the literature points towards the need for prevocational screening for CVD in applicants, especially for specialties or subspecialties that require good color discrimination. Among doctors and healthcare workers, 5% of dichromats and 25% of anomalous trichromats were reported to be unaware of their colorblindness [19]. As a result, this may lead to clinical implications and significantly hinder their ability to accurately diagnose or stage certain diseases. In fact, a previous study on CVD that assessed the responses of physicians to accurately identify certain clinical signs through colored photographs showed that they were less likely to correctly identify the specified clinical signs and were less confident in their responses in comparison to the control group with normal color vision [20]. A colorblind ophthalmologist also described difficulties in diagnosing fundus pathologies, wherein lesions that are normally pigmented as red appeared as blue, including the red ophthalmoscopic reflex [21]. Another challenge that may be faced among colorblind ophthalmologists during retinal examination is that of distinguishing artifacts (e.g., melanin pigment) from other disease manifestations (e.g., retinal hemorrhages), as these lesions may have a similar appearance upon examination [22]. This would lead to falsely reporting a higher stage than the actual stage. Finally, differentiating retinal hemorrhages and other manifestations in patients with chorioretinal degeneration, wherein the background of the retina appears to be darker than normal, poses an additional difficulty [22]. These limitations further portray the crucial importance of correct color identification on clinical practice, diagnosis, and staging of eye diseases.
Color serves as a crucial diagnostic characteristic of choroidal tumors. Melanomas typically exhibit shades of brown, gray, black, or white, whereas hemangiomas are commonly orange-red. Most metastases appear white, except for renal and carcinoid secondaries, which can appear orange. Although digital cameras, such as the widefield camera, are extensively used for screening and apply various algorithms to recreate fundus colors, the resulting images may not reflect reality and may mislead clinicians. Therefore, tumors should be examined ophthalmoscopically instead of solely relying on photographs [6,7,8,9,10,11,12].
Correct identification of colors is essential for certain careers and requires screening prior to job placement. Although some medical schools in the UK and all in Taiwan have implemented testing for colorblindness as a prerequisite for medical school, it is not a requirement in the majority of medical schools globally [23]. Screening can test for the severity of colorblindness, provide counseling, and help individuals choose career paths that do not require accurate color identification. Although the impact of medical errors resulting from colorblindness on patient care is complex to establish, it is strongly recommended for patient safety. While clinical appearance is not the sole factor in diagnosing choroidal tumors, various techniques such as fundus examination, ultrasound, angiography, and OCT may improve the diagnostic accuracy of colorblind ophthalmologists. Although our study showed limited ability of participants with colorblindness to diagnose choroidal tumors based on clinical images, they can still distinguish benign from malignant lesions, thus avoiding harm to patients. Utilizing other diagnostic tools is expected to enhance their tumor-diagnosis abilities, although this aspect was not analyzed in our study.
This study had many limitations that should be considered in future research. We were limited in the number of cases we could include in the survey, as we wanted to keep it from becoming tedious for participants to complete; therefore, we chose clear-cut diagnostic cases that would not cause confusion for general ophthalmologists in order to accurately gauge the capabilities of colorblind participants. Furthermore, the participants knew that the only photos they would have to evaluate were ones showing either a normal fundus or a classic choroidal nevus, a classic circumscribed choroidal hemangioma, a classic choroidal melanoma, or a classic metastatic choroidal tumor, and that their “diagnostic accuracy” would be expected to be substantially higher than in real life where the differential diagnosis should be wider as it includes other choroidal tumors such as amelanotic choroidal nevi, borderline melanocytic choroidal tumors, choroidal neurilemomas, choroidal osteomas, retinal astrocytomas, subretinal infiltrates of primary vitreoretinal lymphoma, and a variety of fundus lesions that can simulate a malignant or benign fundus neoplasm (e.g., subretinal hematoma, localized suprachoroidal hematoma, solitary hypertrophy of the retinal pigment epithelium, inflammatory chorioretinal granuloma, and fundus lesions of sclerochoroidal calcification). Therefore, we suggest that future studies consider evaluating smaller amelanotic lesions and other lesions in the differential diagnosis to be closer to real life. One more limitation inherent in the design of this report is that while we showcase a lower diagnostic accuracy for images simulating CVD, in fact, fundus lesions are usually distinguished based on size, color, consistency, and supporting features. Supporting features might be drusen, orange pigments, and calcifications, among others. Future studies should focus on further exploring the value of such features on diagnostic accuracy. Moreover, it is also worth mentioning that the role of participants’ experience was not found to be a significant contributor, and this finding should be further explored in future studies.

5. Conclusions

CVD can affect an ophthalmologist’s ability to diagnose fundus pathologies. We conclude that simulated protanopia and deuteranopia CVD affected the accuracy of diagnosing several fundus lesions, including circumscribed hemangioma, choroidal nevus, choroidal melanoma and metastasis, and even normal fundus images. However, participants were still able to determine if the lesion was benign or malignant, which might warrant referral to specialist care.

Author Contributions

M.E. (Mutasem Elfalah), S.A.A. and Y.A.Y. contributed to research conception, data collection, analysis, and writing. N.E.A.-Y., M.M., I.A., D.R., M.E. (Mohammad Elfalah), M.A. and F.A. contributed to data collection and manuscript writing. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported in part by King Hussein Cancer Center (Amman, Jordan), and The University of Jordan (Amman, Jordan).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of the King Hussein Cancer Center (KHCC), Amman, Jordan (22 KHCC 008).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. No identifying data were used in this paper.

Data Availability Statement

Data are available on reasonable request upon demand made to the corresponding authors.

Conflicts of Interest

The authors declare no conflict of interest in this paper.

References

  1. Campbell, J.L.; Spalding, A.J.; Mir, F.A.; Birch, J. Doctors and the Assessment of Clinical Photographs—Does Colour Blindness Matter? Br. J. Gen. Pract. J. R. Coll. Gen. Pract. 1999, 49, 459–461. [Google Scholar]
  2. Balasundaram, R.; Reddy, S.C. Prevalence of Colour Vision Deficiency among Medical Students and Health Personnel. Malays. Fam. Physician Off. J. Acad. Fam. Physicians Malays. 2006, 1, 52–53. [Google Scholar]
  3. Chan, X.B.V.; Goh, S.M.S.; Tan, N.C. Subjects with Colour Vision Deficiency in the Community: What Do Primary Care Physicians Need to Know? Asia Pac. Fam. Med. 2014, 13, 10. [Google Scholar] [CrossRef] [Green Version]
  4. Shields, C.L.; Manalac, J.; Das, C.; Ferguson, K.; Shields, J.A. Choroidal Melanoma: Clinical Features, Classification, and Top 10 Pseudomelanomas. Curr. Opin. Ophthalmol. 2014, 25, 177–185. [Google Scholar] [CrossRef]
  5. Bornfeld, N.; Biewald, E.; Bauer, S.; Temming, P.; Lohmann, D.; Zeschnigk, M. The Interdisciplinary Diagnosis and Treatment of Intraocular Tumors. Dtsch. Ärztebl. Int. 2018, 115, 106–111. [Google Scholar] [CrossRef] [PubMed]
  6. Schalenbourg, A.; Zografos, L. Pitfalls in colour photography of choroidal tumours. Eye 2013, 27, 224–229. [Google Scholar] [CrossRef] [Green Version]
  7. Solnik, M.; Paduszyńska, N.; Czarnecka, A.M.; Synoradzki, K.J.; Yousef, Y.A.; Chorągiewicz, T.; Rejdak, R.; Toro, M.D.; Zweifel, S.; Dyndor, K.; et al. Imaging of Uveal Melanoma—Current Standard and Methods in Development. Cancers 2022, 14, 3147. [Google Scholar] [CrossRef]
  8. Toro, M.D.; Gozzo, L.; Tracia, L.; Cicciù, M.; Drago, F.; Bucolo, C.; Avitabile, T.; Rejdak, R.; Nowomiejska, K.; Zweifel, S.; et al. New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review. Biomedicines 2021, 9, 1311. [Google Scholar] [CrossRef]
  9. Jain, P.; Finger, P.T.; Damato, B.; Coupland, S.E.; Heimann, H.; Kenawy, N.; Brouwer, N.J.; Marinkovic, M.; Van Duinen, S.G.; Caujolle, J.P.; et al. Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma. JAMA Ophthalmol. 2019, 137, 905–911. [Google Scholar] [CrossRef] [Green Version]
  10. Jaradat, I.; Zewar, A.; AlNawaiseh, I.; AlRawashdeh, K.; Khurma, S.; Mehyar, M.; Abdeen, G.; Yousef, Y.A. Characteristics, management, and outcome of patients with uveal melanoma treated by Iodine-125 radioactive plaque therapy in a single tertiary cancer center in Jordan. Saudi J. Ophthalmol. 2018, 32, 130–133. [Google Scholar] [CrossRef]
  11. Zewar, A.; Nawaiseh, I.; Jaradat, I.; Khzouz, J.; Alrawashdeh, K.; Abdeen, G.; Mehyar, M.; Khurma, S.; Yousef, Y.A. Management and Outcome of Uveal Melanoma in a Single Tertiary Cancer Center in Jordan. Turk Patoloji Derg. 2016, 32, 186–192. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Nawaiseh, I.; Sultan, I.; Mehyar, M.; Haddad, H.; Yousef, Y.A. Amelanotic choroidal melanoma in 16-month-old child. Can. J. Ophthalmol. 2013, 48, e87–e90. [Google Scholar] [CrossRef] [PubMed]
  13. Singh, A.D.; Kalyani, P.; Topham, A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology 2005, 112, 1784–1789. [Google Scholar] [CrossRef]
  14. Maheshwari, A.; Finger, P.T. Cancers of the eye. Cancer Metastasis Rev. 2018, 37, 677–690. [Google Scholar] [CrossRef] [PubMed]
  15. Yousef, Y.A.; Finger, P.T. Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma. Int. J. Radiat. Oncol. Biol. Phys. 2012, 83, 1107–1112. [Google Scholar] [CrossRef]
  16. Schindelin, J.; Arganda-Carreras, I.; Frise, E.; Kaynig, V.; Longair, M.; Pietzsch, T.; Preibisch, S.; Rueden, C.; Saalfeld, S.; Schmid, B.; et al. Fiji—An Open Source Platform for Biological Image Analysis. Nat. Methods 2012, 9, 676–682. [Google Scholar] [CrossRef] [Green Version]
  17. Lillo, J.; Alvaro, L.; Moreira, H. An Experimental Method for the Assessment of Color Simulation Tools. J. Vis. 2014, 14, 15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. AlRyalat, S.A.; Muhtaseb, R.; Alshammari, T. Simulating a Colour-Blind Ophthalmologist for Diagnosing and Staging Diabetic Retinopathy. Eye 2020, 35, 2229–2232. [Google Scholar] [CrossRef]
  19. Steward, J.M.; Cole, B.L. What Do Color Vision Defectives Say about Everyday Tasks? Optom. Vis. Sci. Off. Publ. Am. Acad. Optom. 1989, 66, 288–295. [Google Scholar] [CrossRef]
  20. Goh, S.; Chan, V.; Tan, N. Colour Vision Deficiency: Is It a Handicap? A Narrative Review of Its Impact on Medical & Dental Education and Practice. Proc. Singap. Healthc. 2014, 23, 149–157. [Google Scholar]
  21. Spalding, J.A. Colour Vision Deficiency in the Medical Profession. Br. J. Gen. Pract. 1999, 49, 469–475. [Google Scholar] [PubMed]
  22. Spalding, J.A.B.; Cole, B.L.; Mir, F.A. Advice for Medical Students and Practitioners with Colour Vision Deficiency: A Website Resource. Clin. Exp. Optom. 2010, 93, 39–41. [Google Scholar] [CrossRef] [PubMed]
  23. Pandit, R.; Dhakal, R. Assessment of Color Vision among Health Science Students. Nepal Med. Coll. J. 2020, 22, 49–53. [Google Scholar] [CrossRef]
Figure 1. Fundus images for normal fundus (A), under simulated protanopia (B), deuteranopia (C), and tritanopia (D).
Figure 1. Fundus images for normal fundus (A), under simulated protanopia (B), deuteranopia (C), and tritanopia (D).
Jcm 12 02744 g001
Figure 2. Fundus images for circumscribed choroidal hemangioma (A), under simulated protanopia (B), deuteranopia (C), and tritanopia (D).
Figure 2. Fundus images for circumscribed choroidal hemangioma (A), under simulated protanopia (B), deuteranopia (C), and tritanopia (D).
Jcm 12 02744 g002
Figure 3. Fundus images for choroidal metastasis (A), under simulated protanopia (B), deuteranopia (C), and tritanopia (D).
Figure 3. Fundus images for choroidal metastasis (A), under simulated protanopia (B), deuteranopia (C), and tritanopia (D).
Jcm 12 02744 g003
Figure 4. Fundus images for malignant melanoma (A), under simulated protanopia (B), deuteranopia (C), and tritanopia (D).
Figure 4. Fundus images for malignant melanoma (A), under simulated protanopia (B), deuteranopia (C), and tritanopia (D).
Jcm 12 02744 g004
Figure 5. Fundus images for choroidal nevus (A), under simulated protanopia (B), deuteranopia (C), and tritanopia (D).
Figure 5. Fundus images for choroidal nevus (A), under simulated protanopia (B), deuteranopia (C), and tritanopia (D).
Jcm 12 02744 g005
Table 1. Comparing diagnostic accuracy between simulated and non-simulated images for various types of choroidal lesions.
Table 1. Comparing diagnostic accuracy between simulated and non-simulated images for various types of choroidal lesions.
Non-Simulated Images Diagnosis ScoreSimulated Protanopia Images Diagnosis ScoreSimulated Deuteranopia Images Diagnosis ScoreSimulated Tritanopia Images Diagnosis Score
Choroidal LesionCorrect (%)Correct (%)p ValueCorrect (%)p ValueCorrect (%)p Value
NormalDiagnosis41 (100%)32 (78%)0.00233 (81%)0.00540 (98%)1.00
Need for referral41 (100%)40 (98%)1.0040 (98%)1.0041 (100%)1.00
HemangiomaDiagnosis16 (39%)5 (12%)0.016 (15%)0.0213 (32%)0.64
Need for referral38 (93%)31 (76%)0.7034 (83%)0.3135 (85%)0.47
NevusDiagnosis36 (88%)26 (63%)0.01924 (59%)0.00534 (83%)0.75
Need for referral39 (95%)32 (78%)0.00730 (73%)0.00338 (93%)1.00
MelanomaDiagnosis38 (93%)30 (73%)0.0330 (73%)0.0336 (88%)0.70
Need for referral41 (100%)39 (95%)0.4940 (98%)1.0041 (100%)1.00
MetastasisDiagnosis30 (73%)19 (46%)0.02418 (44%)0.01326 (63%)0.47
Need for referral38 (93%)34 (83%)0.3135 (85%)0.4839 (95%)1.00
Number of participants who correctly diagnosed the image, and number of those who decided correctly if this patient had a disease that needs referral or not. The correct answer for Melanoma and metastasis is that they need referral, while the correct answer for the others is that they do not need referral.
Table 2. Comparing accuracy in diagnosing simulated and non-simulated images between general ophthalmologists on one side and retina specialists and ocular oncologists on the other side.
Table 2. Comparing accuracy in diagnosing simulated and non-simulated images between general ophthalmologists on one side and retina specialists and ocular oncologists on the other side.
41 Participants (41)Specialty
Overall (41)General Ophthalmologists (28)Retina Specialist & Ocular Oncologist (13)p Value
N (%)N (%)N (%)
Non-simulated images diagnosis scoreOverall Score36 (88%)23 (82%)13 (100%)0.159
Benign vs. Malignant40 (98%)27 (96%)13 (100%)1.00
p value0.2010.191.00
Simulated protanopia images diagnosis scoreOverall Score30 (%)20 (%)10 (%)1.00
Benign vs. Malignant38 (%)26 (%)12 (%)1.00
p value0.0370.070.59
Simulated deuteranopia images diagnosis scoreOverall Score28 (%)18 (%)10 (%)0.49
Benign vs. Malignant37 (%)25 (%)12 (%)0.45
p value0.0270.0550.59
Simulated tritanopia images diagnosis ScoreOverall Score35 (%)23 (%)12 (%)0.644
Benign vs. Malignant39 (%)26 (%)13 (%)1.00
p value0.260.421.00
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Elfalah, M.; AlRyalat, S.A.; Abu-Yaghi, N.E.; Mohammad, M.; AlNawiaseh, I.; Rayyan, D.; Albliwi, M.; Elfalah, M.; AlSarairah, F.; Yousef, Y.A. The Impact of Color Vision Deficiency on the Capability of Ophthalmologists to Diagnose Benign and Malignant Choroidal Tumors. J. Clin. Med. 2023, 12, 2744. https://doi.org/10.3390/jcm12072744

AMA Style

Elfalah M, AlRyalat SA, Abu-Yaghi NE, Mohammad M, AlNawiaseh I, Rayyan D, Albliwi M, Elfalah M, AlSarairah F, Yousef YA. The Impact of Color Vision Deficiency on the Capability of Ophthalmologists to Diagnose Benign and Malignant Choroidal Tumors. Journal of Clinical Medicine. 2023; 12(7):2744. https://doi.org/10.3390/jcm12072744

Chicago/Turabian Style

Elfalah, Mutasem, Saif Aldeen AlRyalat, Nakhleh E. Abu-Yaghi, Mona Mohammad, Ibrahim AlNawiaseh, Deema Rayyan, Moath Albliwi, Mohammad Elfalah, Fawaz AlSarairah, and Yacoub A. Yousef. 2023. "The Impact of Color Vision Deficiency on the Capability of Ophthalmologists to Diagnose Benign and Malignant Choroidal Tumors" Journal of Clinical Medicine 12, no. 7: 2744. https://doi.org/10.3390/jcm12072744

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop